Q-linea AB (publ) QLINEA
Updated: 9 Aug 2026
No signal published yet
We already track Q-linea and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Q-linea AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Q-linea free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On July 10, 2026, Q-linea published its interim report for the second quarter of 2026, reporting net sales of SEK 1.5 million and an operating result of SEK -31.3 million. During the period, the company signed three new commercial contracts in Italy and received FDA clearance in the United States for an expanded ASTar blood testing menu. Additionally, Annika Blondeau Henriksson was appointed as interim CFO in May 2026.
What Firelda Watch includes for Q-linea AB (publ)
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Q-linea AB (publ)? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Q-linea free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more